US 2022/0140259 A1Application

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Publication Date:2022-05-05

•20 Claims

•4 Drawing Sheets

Abstract

Provided are a compound including a ligand L_Aof Formula I

that are useful as emitters in organic light emitting devices.

Metadata

Assignee

Universal Display Corporation

Inventors

Jui-Yi TSAI
Alexey Borisovich DYATKIN
Walter YEAGER
Pierre-Luc T. BOUDREAULT

Application Information

Application Number:US 17/574,078

Filing Date:2022-01-12

Priority Date:2019-08-21

Classifications

IPC:

H01L51/00C07F15/00C09K11/06

Patent Drawings (4 sheets)

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a continuation-in-part of copending U.S. patent application Ser. No. 16/938,948, filed Jul. 25, 2020, which in turn claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 62/889,600, filed on Aug. 21, 2019, the entire contents of both applications are incorporated herein by reference.

FIELD

[0002] The present disclosure generally relates to organometallic compounds and formulations and their various uses including as emitters in devices such as organic light emitting diodes and related electronic devices.

BACKGROUND

[0003] Opto-electronic devices that make use of organic materials are becoming increasingly desirable for various reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials.

[0004] OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting.

[0005] One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively, the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single emissive layer (EML) device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.

SUMMARY

[0006] In one aspect, the present disclosure provides a compound comprising a ligand L_Aof Formula I

wherein: rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X¹-X⁸are each independently C or N; no more than two X¹-X⁸in the same ring are N; X¹-X⁴is C if it is attached to Z¹; Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′; Z¹and Z²are each independently C or N; R^A, R^B, R^C, and R^Deach represents zero, mono, or up to a maximum allowed substitution to its associated ring; R, R′, R^A, R^B, R^C, and R^Deach independently a hydrogen or a substituent selected from the group consisting of the general substituents defined herein; at least one R^Dis a carbocyclic or heterocyclic group, and any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring, wherein the ligand L_Ais coordinated to a metal M forming a 5-membered chelate ring; wherein M can be coordinated to other ligands; wherein the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

[0007] In another aspect, the present disclosure provides a formulation of the compound of the present disclosure.

[0008] In yet another aspect, the present disclosure provides an OLED having an organic layer comprising the compound of the present disclosure.

[0009] In yet another aspect, the present disclosure provides a consumer product comprising an OLED with an organic layer comprising the compound of the present disclosure.

BRIEF DESCRIPTION OF THE DRAWINGS

[0010] FIG. 1 shows an organic light emitting device.

[0011] FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

[0012] FIG. 3.shows the transition dipolar moment of the inventive compound (L_A1-5-9)(L_B28)₂.

DETAILED DESCRIPTION

A. Terminology

[0013] Unless otherwise specified, the below terms used herein are defined as follows:

[0014] As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

[0015] As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

[0016] As used herein, “solution processable” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

[0017] A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

[0018] As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

[0019] As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

[0020] The terms “halo,” “halogen,” and “halide” are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.

[0021] The term “acyl” refers to a substituted carbonyl radical (C(O)—R_s).

[0022] The term “ester” refers to a substituted oxycarbonyl (—O—C(O)—R_sor —C(O)—O—R_s) radical.

[0023] The term “ether” refers to an —OR_sradical.

[0024] The terms “sulfanyl” or “thio-ether” are used interchangeably and refer to a —SR_sradical.

[0025] The term “selenyl” refers to a —SeR_sradical.

[0026] The term “sulfinyl” refers to a —S(O)—R_sradical.

[0027] The term “sulfonyl” refers to a —SO₂—R_sradical.

[0028] The term “phosphino” refers to a —P(R_s)₃radical, wherein each R_scan be same or different.

[0029] The term “silyl” refers to a —Si(R_s)₃radical, wherein each R_scan be same or different.

[0030] The term “germyl” refers to a —Ge(R_s)₃radical, wherein each R_scan be same or different.

[0031] The term “boryl” refers to a —B(R_s)₂radical or its Lewis adduct —B(R_s)₃radical, wherein R_scan be same or different.

[0032] In each of the above, R_scan be hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combination thereof. Preferred R_sis selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and combination thereof.

[0033] The term “alkyl” refers to and includes both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.

[0034] The term “cycloalkyl” refers to and includes monocyclic, polycyclic, and spiro alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.

[0035] The terms “heteroalkyl” or “heterocycloalkyl” refer to an alkyl or a cycloalkyl radical, respectively, having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Additionally, the heteroalkyl or heterocycloalkyl group may be optionally substituted.

[0036] The term “alkenyl” refers to and includes both straight and branched chain alkene radicals. Alkenyl groups are essentially alkyl groups that include at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl groups are essentially cycloalkyl groups that include at least one carbon-carbon double bond in the cycloalkyl ring. The term “heteroalkenyl” as used herein refers to an alkenyl radical having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl, cycloalkenyl, or heteroalkenyl group may be optionally substituted.

[0037] The term “alkynyl” refers to and includes both straight and branched chain alkyne radicals. Alkynyl groups are essentially alkyl groups that include at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.

[0038] The terms “aralkyl” or “arylalkyl” are used interchangeably and refer to an alkyl group that is substituted with an aryl group. Additionally, the aralkyl group may be optionally substituted.

[0039] The term “heterocyclic group” refers to and includes aromatic and non-aromatic cyclic radicals containing at least one heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Hetero-aromatic cyclic radicals may be used interchangeably with heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers/thio-ethers, such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and the like. Additionally, the heterocyclic group may be optionally substituted.

[0040] The term “aryl” refers to and includes both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.

[0041] The term “heteroaryl” refers to and includes both single-ring aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. The heteroatoms include, but are not limited to O, S, N, P, B, Si, and Se. In many instances, O, S, or N are the preferred heteroatoms. Hetero-single ring aromatic systems are preferably single rings with 5 or 6 ring atoms, and the ring can have from one to six heteroatoms. The hetero-polycyclic ring systems can have two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. The hetero-polycyclic aromatic ring systems can have from one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.

[0042] Of the aryl and heteroaryl groups listed above, the groups of triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole, and the respective aza-analogs of each thereof are of particular interest.

[0043] The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl, as used herein, are independently unsubstituted, or independently substituted, with one or more general substituents.

[0044] In many instances, the general substituents are selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, boryl, and combinations thereof.

[0045] In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, boryl, and combinations thereof.

[0046] In some instances, the more preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, boryl, aryl, heteroaryl, sulfanyl, and combinations thereof.

[0047] In yet other instances, the most preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

[0048] The terms “substituted” and “substitution” refer to a substituent other than H that is bonded to the relevant position, e.g., a carbon or nitrogen. For example, when R¹represents mono-substitution, then one R¹must be other than H (i.e., a substitution). Similarly, when R¹represents di-substitution, then two of R¹must be other than H. Similarly, when R¹represents zero or no substitution, R¹, for example, can be a hydrogen for available valencies of ring atoms, as in carbon atoms for benzene and the nitrogen atom in pyrrole, or simply represents nothing for ring atoms with fully filled valencies, e.g., the nitrogen atom in pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valencies in the ring atoms.

[0049] As used herein, “combinations thereof” indicates that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, an alkyl and deuterium can be combined to form a partial or fully deuterated alkyl group; a halogen and alkyl can be combined to form a halogenated alkyl substituent; and a halogen, alkyl, and aryl can be combined to form a halogenated arylalkyl. In one instance, the term substitution includes a combination of two to four of the listed groups. In another instance, the term substitution includes a combination of two to three groups. In yet another instance, the term substitution includes a combination of two groups. Preferred combinations of substituent groups are those that contain up to fifty atoms that are not hydrogen or deuterium, or those which include up to forty atoms that are not hydrogen or deuterium, or those that include up to thirty atoms that are not hydrogen or deuterium. In many instances, a preferred combination of substituent groups will include up to twenty atoms that are not hydrogen or deuterium.

[0050] The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective aromatic ring can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

[0051] As used herein, “deuterium” refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. Pat. No. 8,557,400, Patent Pub. No. WO 2006/095951, and U.S. Pat. Application Pub. No. US 2011/0037057, which are hereby incorporated by reference in their entireties, describe the making of deuterium-substituted organometallic complexes. Further reference is made to Ming Yan, et al., Tetrahedron 2015, 71, 1425-30 and Atzrodt et al., Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65, which are incorporated by reference in their entireties, describe the deuteration of the methylene hydrogens in benzyl amines and efficient pathways to replace aromatic ring hydrogens with deuterium, respectively.

[0052] It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

[0053] In some instance, a pair of adjacent substituents can be optionally joined or fused into a ring. The preferred ring is a five, six, or seven-membered carbocyclic or heterocyclic ring, includes both instances where the portion of the ring formed by the pair of substituents is saturated and where the portion of the ring formed by the pair of substituents is unsaturated. As used herein, “adjacent” means that the two substituents involved can be on the same ring next to each other, or on two neighboring rings having the two closest available substitutable positions, such as 2, 2′ positions in a biphenyl, or 1, 8 position in a naphthalene, as long as they can form a stable fused ring system.

B. The Compounds of the Present Disclosure

[0054] In one aspect, the present disclosure provides a compound comprising a ligand L_Aof Formula I

wherein: rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X¹-X⁸are each independently C or N; no more than two X¹-X⁸in the same ring are N; X¹-X⁴is C if it is attached to Z¹; Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′; Z¹and Z²are each independently C or N; R^A, R^B, and R^Ceach represents zero, mono, or up to a maximum allowed substitution to its associated ring; R^Drepresents mono, up to the maximum number of allowed substitutions to its associated ring; R, R′, R^A, R^B, R^C, and R^Dare each independently a hydrogen or a substituent selected from the group consisting of the general substituents as defined above; at least one R^Dis a carbocyclic or heterocyclic group, and any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring, wherein the ligand L_Ais coordinated to a metal M through two dashed lines forming a 5-membered chelate ring; wherein M can be coordinated to other ligands; and wherein the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

[0055] In some embodiments, each R, R′, R^A, R^B, R^C, and R^Dcan be independently a hydrogen or a substituent selected from the group consisting of the preferred general substituents defined herein.

[0056] In some embodiments, Y can be selected from the group consisting of O and S.

[0057] In some embodiments, ring A can be selected from the group consisting of pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, triazole, pyrazole, and N-heterocyclic carbene. In some embodiments, ring A is pyridine, imidazole or benzoimidazole. In some embodiments, ring A is imidazole or benzoimidazole.

[0058] In some embodiments, Z¹can be C and Z²can be N.

[0059] In some embodiments, Z¹can be N and Z²can be C.

[0060] In some embodiments, each X¹-X⁸can be C.

[0061] In some embodiments, at least one of X¹-X⁸can be N. In some embodiments, X⁸can be N, the remaining X¹-X⁸can be C.

[0062] In some embodiments, one of X¹-X⁴can be N and can be coordinated to M.

[0063] In some embodiments, ring D can be a 6-membered aromatic ring.

[0064] In some embodiments, at least one R^Dcan be a substituted or unsubstituted 6-membered aromatic ring.

[0065] In some embodiments, at least one R^Dcan be a 5-membered or 6-membered aliphatic ring, which can be further substituted.

[0066] In some embodiments, M can be selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au.

[0067] In some embodiments, M can be selected from the group consisting of Ir and Pt.

[0068] In some embodiments, the ligand L_Aof Formula I can be selected from the group consisting of:

wherein X⁹to X¹³can each be independently C or N; Y¹is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′; and all other variables are as defined for Formula I.

[0069] In some embodiments, the ligand L_Acan be L_Aa-b-chaving the structure of Formula II

wherein: a is an integer from 1 to 20; b is an integer from 1 to 14; c is an integer from 1 to 151, wherein for each a, the substituents R^Band R^C, the point of attachment (“POA”) for the Pyridine and Aryl substituents, and the ligation position are defined as provided in Table 1:

TABLE 1

	Pyridine	Aryl	Ligation
a	POA	POA	position	R^B	R^C


1.	4	6	3	H	H
2.	3	6	2	H	H
3.	2	6	3	H	H
4.	4	7	3	H	H
5.	3	7	2	H	H
6.	2	7	3	H	H
7.	4	8	3	H	H
8.	3	8	2	H	H
9.	2	8	3	H	H
10.	2	6	3	H	H
11.	2	7	3	H	H
12.	2	8	3	H	H
13.	2	9	3	H	H
14.	4	9	3	H	H
15.	3	9	2	H	H
16.	2	9	3	H	H
17.	4	6	3	H	7,9-CD₃
18.	4	6	3	1-CD₃	H
19.	4	3	6	1-CD₃	8-CD₃
20.	4	3	6	H	7-CD₃

wherein the Pyridine substituent in Formula II has the structure of Formula III

and for each b, the substituents R^A1and R^A2are defined as provided in Table 2:

TABLE 2

b	R^A1	R^A2


1.	H	CD₃
2.	CD₃	H
3.	CD₃	CD₃
4.	CD₃	CDMe₂
5.	CD₃	CD₂CMe₃
6.	CD₃	CMe₃
7.	H	CDMe₂
8.	H	CD₂CMe₃
9.	H	CMe₃
10.	CD₂CMe₃	CD₂CMe₃
11.	CD₃	Ph

12.	H

13.	H

14.	H

wherein for each c, the Aryl substituent in Formula II has the structure of Formula E*-D*-, wherein for each c, D* and E* are defined as provided in Table 3, wherein D* can consist of 1 to 3 groups from D₁to D₁₂attached in conjunction:

TABLE 3

c	D*	E*


1.	D_1-#	E₃
2.	D_1-#	E₄
3.	D_1-#	E₅
4.	D_1-#	E₆
5.	D_6-#	E₃
6.	D_6-#	E₄
7.	D_6-#	E₅
8.	D_6-#	E₆
9.	D₁D_1-#	H
10.	D₁D_1-#	E₁
11.	D₁D_1-#	E₂
12.	D₁D_1-#	E₃
13.	D₁D_1-#	E₄
14.	D₁D_1-#	E₅
15.	D₁D_1-#	E₆
16.	D₁D_1-#	E₇
17.	D₁D_1-#	E₈
18.	D₁D_2-#	H
19.	D₁D_2-#	E₂
20.	D₁D_2-#	E₃
21.	D₂D_1-#	E₁
22.	D₁D_1-#	H
23.	D₁D_1-#	E₁
24.	D₁D_1-#	E₂
25.	D₁D_1-#	E₃
26.	D₁D_1-#	E₄
27.	D₁D_1-#	E₅
28.	D₁D_1-#	E₆
29.	D₁D_1-#	E₇
30.	D₁D_1-#	E₈
31.	D₁D_1-#	E₉
32.	D₁D_1-#	CD₃
33.	D₁D_2-#	E₇
34.	D₁D_2-#	E₈
35.	D₂D_2-#	E₅
36.	D₁D_2-#	CD₃
37.	D₂D_1-#	E₂
38.	D₂D_1-#	E₃
39.	D₁D_3-#	E₁
40.	D₁D_3-#	E₂
41.	D₁D_3-#	E₃
42.	D₁D_3-#	E₄
43.	D₁D_3-#	E₅
44.	D₁D_3-#	E₆
45.	D₁D_3-#	E₇
46.	D₁D_3-#	E₈
47.	D₁D_3-#	E₉
48.	D₁D_3-#	CD₃
49.	D₁D_3-#	H
50.	D₃D_1-#	E₁
51.	D₃D_1-#	E₂
52.	D₃D_1-#	E₃
53.	D₃D_1-#	E₄
54.	D₃D_1-#	E₅
55.	D₃D_1-#	E₆
56.	D₃D_1-#	E₇
57.	D₃D_1-#	E₈
58.	D₄D_1-#	E₂
59.	D₄D_1-#	E₃
60.	D₄D_1-#	E₄
61.	D₄D_1-#	E₅
62.	D₄D_1-#	E₆
63.	D₄D_1-#	E₇
64.	D₄D_1-#	E₈
65.	D₁D_4-#	E₁
66.	D₁D_4-#	E₂
67.	D₁D_4-#	E₃
68.	D₁D_4-#	E₄
69.	D₁D_4-#	E₅
70.	D₁D_4-#	E₆
71.	D₁D_4-#	E₇
72.	D₁D_4-#	E₈
73.	D₂D_5-#	E₁
74.	D₂D_5-#	E₂
75.	D₂D_5-#	E₃
76.	D₂D_5-#	E₄
77.	D₂D_5-#	E₅
78.	D₂D_5-#	E₆
79.	D₂D_5-#	E₇
80.	D₂D_5-#	E₈
81.	D₂D_5-#	E₉
82.	D₅D_2-#	E₁
83.	D₅D_2-#	E₂
84.	D₅D_2-#	E₃
85.	D₅D_2-#	E₄
86.	D₅D_2-#	E₅
87.	D₅D_2-#	E₆
88.	D₅D_2-#	E₇
89.	D₅D_2-#	E₈
90.	D₅D_2-#	E₉
91.	D₆D_6-#	H
92.	D₆D_6-#	CD₃
93.	D₆D_6-#	E₁
94.	D₆D_6-#	E₂
95.	D₆D_6-#	E₃
96.	D₆D_6-#	E₄
97.	D₆D_6-#	E₅
98.	D₆D_6-#	E₆
99.	D₆D_6-#	E₇
100.	D₆D_6-#	E₈
101.	D₆D_6-#	E₉
102.	D₈D_8-#	E₁
103.	D₈D_8-#	E₂
104.	D₈D_8-#	E₃
105.	D₈D_8-#	E₄
106.	D₈D_8-#	E₅
107.	D₈D_8-#	E₆
108.	D₈D_8-#	E₇
109.	D₈D_8-#	E₈
110.	D₈D_8-#	E₉
111.	D₉D_1-#	E₂
112.	D₉D_1-#	E₄
113.	D₉D_1-#	E₅
114.	D₉D_1-#	E₆
115.	D₁₀D_1-#	E₂
116.	D₁₀D_1-#	E₄
117.	D₁₀D_1-#	E₅
118.	D₁₀D_1-#	CD₃
119.	D₁₁D_1-#	E₂
120.	D₁₁D_1-#	E₄
121.	D₁₁D_1-#	E₅
122.	D₁₁D_1-#	E₆
123.	D₁₂D_1-#	E₂
124.	D₁₂D_1-#	E₄
125.	D₁₂D_1-#	E₅
126.	D₁₂D_1-#	E₆
127.	D₁D₁D_1-#	H
128.	D₁D₁D_1-#	E₄
129.	D₁D₁D_1-#	E₅
130.	D₁D₁D_1-#	E₆
131.	D₂D₂D_1-#	E₂
132.	D₂D₂D_1-#	E₄
133.	D₂D₂D_1-#	E₅
134.	D₂D₂D_1-#	E₆
135.	D₂D₅D_1-#	E₂
136.	D₂D₅D_1-#	E₄
137.	D₂D₅D_1-#	E₅
138.	D₂D₅D_1-#	E₆
139.	D₅D₂D_1-#	E₂
140.	D₅D₂D_1-#	E₄
141.	D₅D₂D_1-#	E₅
142.	D₅D₂D_1-#	E₆
143.	D₅D₅D_1-#	E₂
144.	D₅D₅D_1-#	E₄
145.	D₅D₅D_1-#	E₅
146.	D₅D₅D_1-#	E₆
147.	D₆D₆D_6-#	E₂
148.	D₆D₆D_6-#	E₄
149.	D₆D₆D_6-#	E₅
150.	D₆D₆D_6-#	E₆
151.	D₁D₈D_8-#	H

wherein the groups D₁to D₁₂have the following structures:

wherein # shows attachment direction to dibezofuran/dibenzothiphene core, and * shows attachment direction to substituent E*; and wherein E1 to E9 are defined as follows:

[0070] In some embodiments, the ligand L_Acan be selected from the group consisting of

[0071] In some embodiments, the compound has a formula of M(L_A)_p(L_B)_q(L_C)_rwherein L_Band L_Care each a bidentate ligand; and wherein p is 1, 2, or 3; q is 0, 1, or 2; r is 0, 1, or 2; and p+q+r is the oxidation state of the metal M.

[0072] In some embodiments, the compound has a formula selected from the group consisting of Ir(L_A)₃, Ir(L_A)(L_B)₂, Ir(L_A)₂(L_B), Ir(L_A)₂(L_C), and Ir(L_A)(L_B)(L_C); and wherein L_A, L_B, and L_Care different from each other.

[0073] In some embodiments, the compound has a formula of M(L_Aa-b-c)_p(L_B)_q(L_C)_r, wherein L_Aa-b-care as defined above, and L_Band L_Care each a bidentate ligand; and wherein p is 1, 2, or 3; q is 0, 1, or 2; r is 0, 1, or 2; and p+q+r is the oxidation state of the metal M.

[0074] In some embodiments, the compound has a formula selected from the group consisting of Ir(L_Aa-b-c)₃, Ir(L_Aa-b-c)(L_B)₂, Ir(L_Aa-b-c)₂(L_B), Ir(L_Aa-b-c)₂(L_C), and Ir(L_Aa-b-c)(L_B)(L_C); and wherein L_Aa-b-care as defined above, and L_Aa-b-c, L_B, and L_Care different from each other.

[0075] In some embodiments, the compound has a formula of Pt(L_A)(L_B); and wherein L_Aand L_Bcan be same or different.

[0076] In some embodiments, the compound has a formula of Pt(L_Aa-b-c)(L_B); and wherein L_Aa-b-care as defined above, and L_Aa-b-cand L_Bcan be same or different.

[0077] In some embodiments, the ligand L_Aand L_Bare connected to form a tetradentate ligand.

[0078] In some embodiments, the ligand L_Aa-b-cand L_Bare connected to form a tetradentate ligand.

[0079] In some of the above embodiments, ligands L_Band L_Ceach can be independently selected from the group consisting of:

wherein each Y¹to Y¹³are independently selected from the group consisting of C and N; Y¹is selected from the group consisting of BR_e, NR_e, PR_e, O, S, Se, C═O, S═O, SO₂, CR_eR_f, SiR_eR_f, and GeR_eR_f; R_eand R_fcan be fused or joined to form a ring; each R_a, R_b, R_c, and R_dindependently represents from zero, mono, or up to the maximum number of allowed substitutions to its associated ring; each R_a, R_b, R_c, R_d, R_eand R_fis independently a hydrogen or a substituent selected from the group consisting of the general substituents as defined above; and wherein any two adjacent substituents of R_a, R_b, R_c, and R_dcan be fused or joined to form a ring or form a multidentate ligand.

[0080] In some of the above embodiments, ligands L_Band L_Ccan be each independently selected from the group consisting of:

[0081] In some of the above embodiments, L_Bcan be selected from the group consisting of L_B1through L_B324whose structures are defined in LIST1 below:

[0082] In some of the above embodiments, L_Bcan be selected from the group consisting of: L_B1, L_B2, L_B18, L_B28, L_B38, L_B108, L_B118, L_B122, L_B124, L_B126, L_B128, L_B130, L_B32, L_B134, L_B136, L_B138, L_B140, L_B142, L_B144, L_B156, L_B58, L_B160, L_B162, L_B164, L_B168, L_B172, L_B175, L_B204, L_B206, L_B214, L_B216, L_B218, L_B220, L_B222, L_B231, L_B233, L_B235, L_B237, L_B240, L_B242, L_B244, L_B246, L_B248, L_B250, L_B252, L_B254, L_B256, L_B258, L_B260, L_B262, L_B263, L_B264, L_B265, L_B266, L_B267, L_B268, L_B269, and L_B270.

[0083] In some of the above embodiments, L_Bcan be selected from the group consisting of: L_B1, L_B2, L_B18, L_B28, L_B38, L_B108, L_B118, L_B122, L_B124, L_B126, L_B128, L_B132, L_B136, L_B138, L_B142, L_B156, L_B162, L_B204, L_B206, L_B214, L_B216, L_B218, L_B220, L_B231, L_B233, L_B237, L_B264, L_B265, L_B266, L_B267, L_B268, L_B269, and L_B270.

[0084] In some of the above embodiemnts, L_Ccan be selected from the group consisting of:

[0085] L_Cj-Ihaving structures based on

and

[0086] L_Cj-IIhaving structures based on

wherein j is an integer from 1 to 768, wherein for each L_Cjin L_Cj-Iand L_Cj-II, R¹and R²are defined as provided below:


L_Cj	R¹	R²

L_C1	R^D1	R^D1
L_C2	R^D2	R^D2
L_C3	R^D3	R^D3
L_C4	R^D4	R^D4
L_C5	R^D5	R^D5
L_C6	R^D6	R^D6
L_C7	R^D7	R^D7
L_C8	R^D8	R^D8
L_C9	R^D9	R^D9
L_C10	R^D10	R^D10
L_C11	R^D11	R^D11
L_C12	R^D12	R^D12
L_C13	R^D13	R^D13
L_C14	R^D14	R^D14
L_C15	R^D15	R^D15
L_C16	R^D16	R^D16
L_C17	R^D17	R^D17
L_C18	R^D18	R^D18
L_C19	R^D19	R^D19
L_C20	R^D20	R^D20
L_C21	R^D21	R^D21
L_C22	R^D22	R^D22
L_C23	R^D23	R^D23
L_C24	R^D24	R^D24
L_C25	R^D25	R^D25
L_C26	R^D26	R^D26
L_C27	R^D27	R^D27
L_C28	R^D28	R^D28
L_C29	R^D29	R^D29
L_C30	R^D30	R^D30
L_C31	R^D31	R^D31
L_C32	R^D32	R^D32
L_C33	R^D33	R^D33
L_C34	R^D34	R^D34
L_C35	R^D35	R^D35
L_C36	R^D36	R^D36
L_C37	R^D37	R^D37
L_C38	R^D38	R^D38
L_C39	R^D39	R^D39
L_C40	R^D40	R^D40
L_C41	R^D41	R^D41
L_C42	R^D42	R^D42
L_C43	R^D43	R^D43
L_C44	R^D44	R^D44
L_C45	R^D45	R^D45
L_C46	R^D46	R^D46
L_C47	R^D47	R^D47
L_C48	R^D48	R^D48
L_C49	R^D49	R^D49
L_C50	R^D50	R^D50
L_C51	R^D51	R^D51
L_C52	R^D52	R^D52
L_C53	R^D53	R^D53
L_C54	R^D54	R^D54
L_C55	R^D55	R^D55
L_C56	R^D56	R^D56
L_C57	R^D57	R^D57
L_C58	R^D58	R^D58
L_C59	R^D59	R^D59
L_C60	R^D60	R^D60
L_C61	R^D61	R^D61
L_C62	R^D62	R^D62
L_C63	R^D63	R^D63
L_C64	R^D64	R^D64
L_C65	R^D65	R^D65
L_C66	R^D66	R^D66
L_C67	R^D67	R^D67
L_C68	R^D68	R^D68
L_C69	R^D69	R^D69
L_C70	R^D70	R^D70
L_C71	R^D71	R^D71
L_C72	R^D72	R^D72
L_C73	R^D73	R^D73
L_C74	R^D74	R^D74
L_C75	R^D75	R^D75
L_C76	R^D76	R^D76
L_C77	R^D77	R^D77
L_C78	R^D78	R^D78
L_C79	R^D79	R^D79
L_C80	R^D80	R^D80
L_C81	R^D81	R^D81
L_C82	R^D82	R^D82
L_C83	R^D83	R^D83
L_C84	R^D84	R^D84
L_C85	R^D85	R^D85
L_C86	R^D86	R^D86
L_C87	R^D87	R^D87
L_C88	R^D88	R^D88
L_C89	R^D89	R^D89
L_C90	R^D90	R^D90
L_C91	R^D91	R^D91
L_C92	R^D92	R^D92
L_C93	R^D93	R^D93
L_C94	R^D94	R^D94
L_C95	R^D95	R^D95
L_C96	R^D96	R^D96
L_C97	R^D97	R^D97
L_C98	R^D98	R^D98
L_C99	R^D99	R^D99
L_C100	R^D100	R^D100
L_C101	R^D101	R^D101
L_C102	R^D102	R^D102
L_C103	R^D103	R^D103
L_C104	R^D104	R^D104
L_C105	R^D105	R^D105
L_C106	R^D106	R^D106
L_C107	R^D107	R^D107
L_C108	R^D108	R^D108
L_C109	R^D109	R^D109
L_C110	R^D110	R^D110
L_C111	R^D111	R^D111
L_C112	R^D112	R^D112
L_C113	R^D113	R^D113
L_C114	R^D114	R^D114
L_C115	R^D115	R^D115
L_C116	R^D116	R^D116
L_C117	R^D117	R^D117
L_C118	R^D118	R^D118
L_C119	R^D119	R^D119
L_C120	R^D120	R^D120
L_C121	R^D121	R^D121
L_C122	R^D122	R^D122
L_C123	R^D123	R^D123
L_C124	R^D124	R^D124
L_C125	R^D125	R^D125
L_C126	R^D126	R^D126
L_C127	R^D127	R^D127
L_C128	R^D128	R^D128
L_C129	R^D129	R^D129
L_C130	R^D130	R^D130
L_C131	R^D131	R^D131
L_C132	R^D132	R^D132
L_C133	R^D133	R^D133
L_C134	R^D134	R^D134
L_C135	R^D135	R^D135
L_C136	R^D136	R^D136
L_C137	R^D137	R^D137
L_C138	R^D138	R^D138
L_C139	R^D139	R^D139
L_C140	R^D140	R^D140
L_C141	R^D141	R^D141
L_C142	R^D142	R^D142
L_C143	R^D143	R^D143
L_C144	R^D144	R^D144
L_C145	R^D145	R^D145
L_C146	R^D146	R^D146
L_C147	R^D147	R^D147
L_C148	R^D148	R^D148
L_C149	R^D149	R^D149
L_C150	R^D150	R^D150
L_C151	R^D151	R^D151
L_C152	R^D152	R^D152
L_C153	R^D153	R^D153
L_C154	R^D154	R^D154
L_C155	R^D155	R^D155
L_C156	R^D156	R^D156
L_C157	R^D157	R^D157
L_C158	R^D158	R^D158
L_C159	R^D159	R^D159
L_C160	R^D160	R^D160
L_C161	R^D161	R^D161
L_C162	R^D162	R^D162
L_C163	R^D163	R^D163
L_C164	R^D164	R^D164
L_C165	R^D165	R^D165
L_C166	R^D166	R^D166
L_C167	R^D167	R^D167
L_C168	R^D168	R^D168
L_C169	R^D169	R^D169
L_C170	R^D170	R^D170
L_C171	R^D171	R^D171
L_C172	R^D172	R^D172
L_C173	R^D173	R^D173
L_C174	R^D174	R^D174
L_C175	R^D175	R^D175
L_C176	R^D176	R^D176
L_C177	R^D177	R^D177
L_C178	R^D178	R^D178
L_C179	R^D179	R^D179
L_C180	R^D180	R^D180
L_C181	R^D181	R^D181
L_C182	R^D182	R^D182
L_C183	R^D183	R^D183
L_C184	R^D184	R^D184
L_C185	R^D185	R^D185
L_C186	R^D186	R^D186
L_C187	R^D187	R^D187
L_C188	R^D188	R^D188
L_C189	R^D189	R^D189
L_C190	R^D190	R^D190
L_C191	R^D191	R^D191
L_C192	R^D192	R^D192
L_C193	R^D1	R^D3
L_C194	R^D1	R^D4
L_C195	R^D1	R^D5
L_C196	R^D1	R^D9
L_C197	R^D1	R^D10
L_C198	R^D1	R^D17
L_C199	R^D1	R^D18
L_C200	R^D1	R^D20
L_C201	R^D1	R^D22
L_C202	R^D1	R^D37
L_C203	R^D1	R^D40
L_C204	R^D1	R^D41
L_C205	R^D1	R^D42
L_C206	R^D1	R^D43
L_C207	R^D1	R^D48
L_C208	R^D1	R^D49
L_C209	R^D1	R^D50
L_C210	R^D1	R^D54
L_C211	R^D1	R^D55
L_C212	R^D1	R^D58
L_C213	R^D1	R^D59
L_C214	R^D1	R^D78
L_C215	R^D1	R^D79
L_C216	R^D1	R^D81
L_C217	R^D1	R^D87
L_C218	R^D1	R^D88
L_C219	R^D1	R^D89
L_C220	R^D1	R^D93
L_C221	R^D1	R^D116
L_C222	R^D1	R^D117
L_C223	R^D1	R^D118
L_C224	R^D1	R^D119
L_C225	R^D1	R^D120
L_C226	R^D1	R^D133
L_C227	R^D1	R^D134
L_C228	R^D1	R^D135
L_C229	R^D1	R^D136
L_C230	R^D1	R^D143
L_C231	R^D1	R^D144
L_C232	R^D1	R^D145
L_C233	R^D1	R^D146
L_C234	R^D1	R^D147
L_C235	R^D1	R^D149
L_C236	R^D1	R^D151
L_C237	R^D1	R^D154
L_C238	R^D1	R^D155
L_C239	R^D1	R^D161
L_C240	R^D1	R^D175
L_C241	R^D4	R^D3
L_C242	R^D4	R^D5
L_C243	R^D4	R^D9
L_C244	R^D4	R^D10
L_C245	R^D4	R^D17
L_C246	R^D4	R^D18
L_C247	R^D4	R^D20
L_C248	R^D4	R^D22
L_C249	R^D4	R^D37
L_C250	R^D4	R^D40
L_C251	R^D4	R^D41
L_C252	R^D4	R^D42
L_C253	R^D4	R^D43
L_C254	R^D4	R^D48
L_C255	R^D4	R^D49
L_C256	R^D4	R^D50
L_C257	R^D4	R^D54
L_C258	R^D4	R^D55
L_C259	R^D4	R^D58
L_C260	R^D4	R^D59
L_C261	R^D4	R^D78
L_C262	R^D4	R^D79
L_C263	R^D4	R^D81
L_C264	R^D4	R^D87
L_C265	R^D4	R^D88
L_C266	R^D4	R^D89
L_C267	R^D4	R^D95
L_C268	R^D4	R^D116
L_C269	R^D4	R^D117
L_C270	R^D4	R^D118
L_C271	R^D4	R^D119
L_C272	R^D4	R^D120
L_C273	R^D4	R^D133
L_C274	R^D4	R^D134
L_C275	R^D4	R^D135
L_C276	R^D4	R^D136
L_C277	R^D4	R^D143
L_C278	R^D4	R^D144
L_C279	R^D4	R^D145
L_C280	R^D4	R^D146
L_C281	R^D4	R^D147
L_C282	R^D4	R^D149
L_C283	R^D4	R^D151
L_C284	R^D4	R^D154
L_C285	R^D4	R^D155
L_C286	R^D4	R^D161
L_C287	R^D4	R^D175
L_C288	R^D9	R^D3
L_C289	R^D9	R^D5
L_C290	R^D9	R^D10
L_C291	R^D9	R^D17
L_C292	R^D9	R^D18
L_C293	R^D9	R^D20
L_C294	R^D9	R^D22
L_C295	R^D9	R^D37
L_C296	R^D9	R^D40
L_C297	R^D9	R^D41
L_C298	R^D9	R^D42
L_C299	R^D9	R^D43
L_C300	R^D9	R^D48
L_C301	R^D9	R^D49
L_C302	R^D9	R^D50
L_C303	R^D9	R^D54
L_C304	R^D9	R^D55
L_C305	R^D9	R^D58
L_C306	R^D9	R^D59
L_C307	R^D9	R^D78
L_C308	R^D9	R^D79
L_C309	R^D9	R^D81
L_C310	R^D9	R^D87
L_C311	R^D9	R^D88
L_C312	R^D9	R^D89
L_C313	R^D9	R^D93
L_C314	R^D9	R^D116
L_C315	R^D9	R^D117
L_C316	R^D9	R^D118
L_C317	R^D9	R^D119
L_C318	R^D9	R^D120
L_C319	R^D9	R^D133
L_C320	R^D9	R^D134
L_C321	R^D9	R^D135
L_C322	R^D9	R^D136
L_C323	R^D9	R^D143
L_C324	R^D9	R^D144
L_C325	R^D9	R^D145
L_C326	R^D9	R^D146
L_C327	R^D9	R^D147
L_C328	R^D9	R^D149
L_C329	R^D9	R^D151
L_C330	R^D9	R^D154
L_C331	R^D9	R^D155
L_C332	R^D9	R^D161
L_C333	R^D9	R^D175
L_C334	R^D10	R^D3
L_C335	R^D10	R^D5
L_C336	R^D10	R^D17
L_C337	R^D10	R^D18
L_C338	R^D10	R^D20
L_C339	R^D10	R^D22
L_C340	R^D10	R^D37
L_C341	R^D10	R^D40
L_C342	R^D10	R^D41
L_C343	R^D10	R^D42
L_C344	R^D10	R^D43
L_C345	R^D10	R^D48
L_C346	R^D10	R^D49
L_C347	R^D10	R^D50
L_C348	R^D10	R^D54
L_C349	R^D10	R^D55
L_C350	R^D10	R^D58
L_C351	R^D10	R^D59
L_C352	R^D10	R^D78
L_C353	R^D10	R^D79
L_C354	R^D10	R^D81
L_C355	R^D10	R^D87
L_C356	R^D10	R^D88
L_C357	R^D10	R^D89
L_C358	R^D10	R^D93
L_C359	R^D10	R^D116
L_C360	R^D10	R^D117
L_C361	R^D10	R^D118
L_C362	R^D10	R^D119
L_C363	R^D10	R^D120
L_C364	R^D10	R^D133
L_C365	R^D10	R^D134
L_C366	R^D10	R^D135
L_C367	R^D10	R^D136
L_C368	R^D10	R^D143
L_C369	R^D10	R^D144
L_C370	R^D10	R^D145
L_C371	R^D10	R^D146
L_C372	R^D10	R^D147
L_C373	R^D10	R^D149
L_C374	R^D10	R^D151
L_C375	R^D10	R^D154
L_C376	R^D10	R^D155
L_C377	R^D10	R^D161
L_C378	R^D10	R^D175
L_C379	R^D17	R^D3
L_C380	R^D17	R^D5
L_C381	R^D17	R^D18
L_C382	R^D17	R^D20
L_C383	R^D17	R^D22
L_C384	R^D17	R^D37
L_C385	R^D17	R^D40
L_C386	R^D17	R^D41
L_C387	R^D17	R^D42
L_C388	R^D17	R^D43
L_C389	R^D17	R^D48
L_C390	R^D17	R^D49
L_C391	R^D17	R^D50
L_C392	R^D17	R^D54
L_C393	R^D17	R^D55
L_C394	R^D17	R^D58
L_C395	R^D17	R^D59
L_C396	R^D17	R^D78
L_C397	R^D17	R^D79
L_C398	R^D17	R^D81
L_C399	R^D17	R^D87
L_C400	R^D17	R^D88
L_C401	R^D17	R^D89
L_C402	R^D17	R^D95
L_C403	R^D17	R^D116
L_C404	R^D17	R^D117
L_C405	R^D17	R^D118
L_C406	R^D17	R^D119
L_C407	R^D17	R^D120
L_C408	R^D17	R^D133
L_C409	R^D17	R^D134
L_C410	R^D17	R^D135
L_C411	R^D17	R^D136
L_C412	R^D17	R^D143
L_C413	R^D17	R^D144
L_C414	R^D17	R^D145
L_C415	R^D17	R^D146
L_C416	R^D17	R^D147
L_C417	R^D17	R^D149
L_C418	R^D17	R^D151
L_C419	R^D17	R^D154
L_C420	R^D17	R^D155
L_C421	R^D17	R^D161
L_C422	R^D17	R^D175
L_C423	R^D50	R^D3
L_C424	R^D50	R^D5
L_C425	R^D50	R^D18
L_C426	R^D50	R^D20
L_C427	R^D50	R^D22
L_C428	R^D50	R^D37
L_C429	R^D50	R^D40
L_C430	R^D50	R^D41
L_C431	R^D50	R^D42
L_C432	R^D50	R^D43
L_C433	R^D50	R^D48
L_C434	R^D50	R^D49
L_C435	R^D50	R^D54
L_C436	R^D50	R^D55
L_C437	R^D50	R^D58
L_C438	R^D50	R^D59
L_C439	R^D50	R^D78
L_C440	R^D50	R^D79
L_C441	R^D50	R^D81
L_C442	R^D50	R^D87
L_C443	R^D50	R^D88
L_C444	R^D50	R^D89
L_C445	R^D50	R^D93
L_C446	R^D50	R^D116
L_C447	R^D50	R^D117
L_C448	R^D50	R^D118
L_C449	R^D50	R^D119
L_C450	R^D50	R^D120
L_C451	R^D50	R^D133
L_C452	R^D50	R^D134
L_C453	R^D50	R^D135
L_C454	R^D50	R^D136
L_C455	R^D50	R^D143
L_C456	R^D50	R^D144
L_C457	R^D50	R^D145
L_C458	R^D50	R^D146
L_C459	R^D50	R^D147
L_C460	R^D50	R^D149
L_C461	R^D50	R^D151
L_C462	R^D50	R^D154
L_C463	R^D50	R^D155
L_C464	R^D50	R^D161
L_C465	R^D50	R^D175
L_C466	R^D55	R^D3
L_C467	R^D55	R^D5
L_C468	R^D55	R^D18
L_C469	R^D55	R^D20
L_C470	R^D55	R^D22
L_C471	R^D55	R^D37
L_C472	R^D55	R^D40
L_C473	R^D55	R^D41
L_C474	R^D55	R^D42
L_C475	R^D55	R^D43
L_C476	R^D55	R^D48
L_C477	R^D55	R^D49
L_C478	R^D55	R^D54
L_C479	R^D55	R^D58
L_C480	R^D55	R^D59
L_C481	R^D55	R^D78
L_C482	R^D55	R^D79
L_C483	R^D55	R^D81
L_C484	R^D55	R^D87
L_C485	R^D55	R^D88
L_C486	R^D55	R^D89
L_C487	R^D55	R^D93
L_C488	R^D55	R^D116
L_C489	R^D55	R^D117
L_C490	R^D55	R^D118
L_C491	R^D55	R^D119
L_C492	R^D55	R^D120
L_C493	R^D55	R^D133
L_C494	R^D55	R^D134
L_C495	R^D55	R^D135
L_C496	R^D55	R^D136
L_C497	R^D55	R^D143
L_C498	R^D55	R^D144
L_C499	R^D55	R^D145
L_C500	R^D55	R^D146
L_C501	R^D55	R^D147
L_C502	R^D55	R^D149
L_C503	R^D55	R^D151
L_C504	R^D55	R^D154
L_C505	R^D55	R^D155
L_C506	R^D55	R^D161
L_C507	R^D55	R^D175
L_C508	R^D116	R^D3
L_C509	R^D116	R^D5
L_C510	R^D116	R^D17
L_C511	R^D116	R^D18
L_C512	R^D116	R^D20
L_C513	R^D116	R^D22
L_C514	R^D116	R^D37
L_C515	R^D116	R^D40
L_C516	R^D116	R^D41
L_C517	R^D116	R^D42
L_C518	R^D116	R^D43
L_C519	R^D116	R^D48
L_C520	R^D116	R^D49
L_C521	R^D116	R^D54
L_C522	R^D116	R^D58
L_C523	R^D116	R^D59
L_C524	R^D116	R^D78
L_C525	R^D116	R^D79
L_C526	R^D116	R^D81
L_C527	R^D116	R^D87
L_C528	R^D116	R^D88
L_C529	R^D116	R^D89
L_C530	R^D116	R^D93
L_C531	R^D116	R^D117
L_C532	R^D116	R^D118
L_C533	R^D116	R^D119
L_C534	R^D116	R^D120
L_C535	R^D116	R^D133
L_C536	R^D116	R^D134
L_C537	R^D116	R^D135
L_C538	R^D116	R^D136
L_C539	R^D116	R^D143
L_C540	R^D116	R^D144
L_C541	R^D116	R^D145
L_C542	R^D116	R^D146
L_C543	R^D116	R^D147
L_C544	R^D116	R^D149
L_C545	R^D116	R^D151
L_C546	R^D116	R^D154
L_C547	R^D116	R^D155
L_C548	R^D116	R^D161
L_C549	R^D116	R^D175
L_C550	R^D143	R^D3
L_C551	R^D143	R^D5
L_C552	R^D143	R^D17
L_C553	R^D143	R^D18
L_C554	R^D143	R^D20
L_C555	R^D143	R^D22
L_C556	R^D143	R^D37
L_C557	R^D143	R^D40
L_C558	R^D143	R^D41
L_C559	R^D143	R^D42
L_C560	R^D143	R^D43
L_C561	R^D143	R^D48
L_C562	R^D143	R^D49
L_C563	R^D143	R^D54
L_C564	R^D143	R^D58
L_C565	R^D143	R^D59
L_C566	R^D143	R^D78
L_C567	R^D143	R^D79
L_C568	R^D143	R^D81
L_C569	R^D143	R^D87
L_C570	R^D143	R^D88
L_C571	R^D143	R^D89
L_C572	R^D143	R^D95
L_C573	R^D143	R^D116
L_C574	R^D143	R^D117
L_C575	R^D143	R^D118
L_C576	R^D143	R^D119
L_C577	R^D143	R^D120
L_C578	R^D143	R^D133
L_C579	R^D143	R^D134
L_C580	R^D143	R^D135
L_C581	R^D143	R^D136
L_C582	R^D143	R^D144
L_C583	R^D143	R^D145
L_C584	R^D143	R^D146
L_C585	R^D143	R^D147
L_C586	R^D143	R^D149
L_C587	R^D143	R^D151
L_C588	R^D143	R^D154
L_C589	R^D143	R^D155
L_C590	R^D143	R^D161
L_C591	R^D143	R^D175
L_C592	R^D144	R^D3
L_C593	R^D144	R^D5
L_C594	R^D144	R^D17
L_C595	R^D144	R^D18
L_C596	R^D144	R^D20
L_C597	R^D144	R^D22
L_C598	R^D144	R^D37
L_C599	R^D144	R^D40
L_C600	R^D144	R^D41
L_C601	R^D144	R^D42
L_C602	R^D144	R^D43
L_C603	R^D144	R^D48
L_C604	R^D144	R^D49
L_C605	R^D144	R^D54
L_C606	R^D144	R^D58
L_C607	R^D144	R^D59
L_C608	R^D144	R^D78
L_C609	R^D144	R^D79
L_C610	R^D144	R^D81
L_C611	R^D144	R^D87
L_C612	R^D144	R^D88
L_C613	R^D144	R^D89
L_C614	R^D144	R^D93
L_C615	R^D144	R^D116
L_C616	R^D144	R^D117
L_C617	R^D144	R^D118
L_C618	R^D144	R^D119
L_C619	R^D144	R^D120
L_C620	R^D144	R^D133
L_C621	R^D144	R^D134
L_C622	R^D144	R^D135
L_C623	R^D144	R^D136
L_C624	R^D144	R^D145
L_C625	R^D144	R^D146
L_C626	R^D144	R^D147
L_C627	R^D144	R^D149
L_C628	R^D144	R^D151
L_C629	R^D144	R^D154
L_C630	R^D144	R^D155
L_C631	R^D144	R^D161
L_C632	R^D144	R^D175
L_C633	R^D145	R^D3
L_C634	R^D145	R^D5
L_C635	R^D145	R^D17
L_C636	R^D145	R^D18
L_C637	R^D145	R^D20
L_C638	R^D145	R^D22
L_C639	R^D145	R^D37
L_C640	R^D145	R^D40
L_C641	R^D145	R^D41
L_C642	R^D145	R^D42
L_C643	R^D145	R^D43
L_C644	R^D145	R^D48
L_C645	R^D145	R^D49
L_C646	R^D145	R^D54
L_C647	R^D145	R^D58
L_C648	R^D145	R^D59
L_C649	R^D145	R^D78
L_C650	R^D145	R^D79
L_C651	R^D145	R^D81
L_C652	R^D145	R^D87
L_C653	R^D145	R^D88
L_C654	R^D145	R^D89
L_C655	R^D145	R^D93
L_C656	R^D145	R^D116
L_C657	R^D145	R^D117
L_C658	R^D145	R^D118
L_C659	R^D145	R^D119
L_C660	R^D145	R^D120
L_C661	R^D145	R^D133
L_C662	R^D145	R^D134
L_C663	R^D145	R^D135
L_C664	R^D145	R^D136
L_C665	R^D145	R^D146
L_C666	R^D145	R^D147
L_C667	R^D145	R^D149
L_C668	R^D145	R^D151
L_C669	R^D145	R^D154
L_C670	R^D145	R^D155
L_C671	R^D145	R^D161
L_C672	R^D145	R^D175
L_C673	R^D146	R^D3
L_C674	R^D146	R^D5
L_C675	R^D146	R^D17
L_C676	R^D146	R^D18
L_C677	R^D146	R^D20
L_C678	R^D146	R^D22
L_C679	R^D146	R^D37
L_C680	R^D146	R^D40
L_C681	R^D146	R^D41
L_C682	R^D146	R^D42
L_C683	R^D146	R^D43
L_C684	R^D146	R^D48
L_C685	R^D146	R^D49
L_C686	R^D146	R^D54
L_C687	R^D146	R^D58
L_C688	R^D146	R^D59
L_C689	R^D146	R^D78
L_C690	R^D146	R^D79
L_C691	R^D146	R^D81
L_C692	R^D146	R^D87
L_C693	R^D146	R^D88
L_C694	R^D146	R^D89
L_C695	R^D146	R^D93
L_C696	R^D146	R^D117
L_C697	R^D146	R^D118
L_C698	R^D146	R^D119
L_C699	R^D146	R^D120
L_C700	R^D146	R^D133
L_C701	R^D146	R^D134
L_C702	R^D146	R^D135
L_C703	R^D146	R^D136
L_C704	R^D146	R^D146
L_C705	R^D146	R^D147
L_C706	R^D146	R^D149
L_C707	R^D146	R^D151
L_C708	R^D146	R^D154
L_C709	R^D146	R^D155
L_C710	R^D146	R^D161
L_C711	R^D146	R^D175
L_C712	R^D133	R^D3
L_C713	R^D133	R^D5
L_C714	R^D133	R^D3
L_C715	R^D133	R^D18
L_C716	R^D133	R^D20
L_C717	R^D133	R^D22
L_C718	R^D133	R^D37
L_C719	R^D133	R^D40
L_C720	R^D133	R^D41
L_C721	R^D133	R^D42
L_C722	R^D133	R^D43
L_C723	R^D133	R^D48
L_C724	R^D133	R^D49
L_C725	R^D133	R^D54
L_C726	R^D133	R^D58
L_C727	R^D133	R^D59
L_C728	R^D133	R^D78
L_C729	R^D133	R^D79
L_C730	R^D133	R^D81
L_C731	R^D133	R^D87
L_C732	R^D133	R^D88
L_C733	R^D133	R^D89
L_C734	R^D133	R^D93
L_C735	R^D133	R^D117
L_C736	R^D133	R^D118
L_C737	R^D133	R^D119
L_C738	R^D133	R^D120
L_C739	R^D133	R^D133
L_C740	R^D133	R^D134
L_C741	R^D133	R^D135
L_C742	R^D133	R^D136
L_C743	R^D133	R^D146
L_C744	R^D133	R^D147
L_C745	R^D133	R^D149
L_C746	R^D133	R^D151
L_C747	R^D133	R^D154
L_C748	R^D133	R^D155
L_C749	R^D133	R^D161
L_C750	R^D133	R^D175
L_C751	R^D175	R^D3
L_C752	R^D175	R^D5
L_C753	R^D175	R^D18
L_C754	R^D175	R^D20
L_C755	R^D175	R^D22
L_C756	R^D175	R^D37
L_C757	R^D175	R^D40
L_C758	R^D175	R^D41
L_C759	R^D175	R^D42
L_C760	R^D175	R^D43
L_C761	R^D175	R^D48
L_C762	R^D175	R^D49
L_C763	R^D175	R^D54
L_C764	R^D175	R^D58
L_C765	R^D175	R^D59
L_C766	R^D175	R^D78
L_C767	R^D175	R^D79
L_C768	R^D175	R^D81

wherein R^D1to R^D192have the following structures:

[0087] In some of the above embodiments of the compound having the formula of M(L_A)_p(L_B)_q(L_C)_r, wherein L_Aand L_Bare as defined above, L_Ccan be selected from the group consisting of only those L_Cj-Iand L_Cj-IIwhose corresponding R¹and R²are defined to be selected from the following structures: R^D1, R^D3, R^D4, R^D5, R^D9, R^D10, R^D17, R^D18, R^D20, R^D22, R^D37, R^D40, R^D41, R^D42, R^D43, R^D48, R^D49, R^D50, R^D54, R^D55, R^D58, R^D59, R^D78, R^D79, R^D81, R^D87, R^D88, R^D89, R^D93, R^D116, R^D117, R^D118, R^D119, R^D120, R^D133, R^D134, R^D135, R^D136, R^D143, R^D144, R^D145, R^D146, R^D147, R^D149, R^D151, R^D154, R^D155, R^D161, R^D175, and R^D190.

[0088] In some of the above embodiments, L_Ccan be selected from the group consisting of only those L_Cj-Iand L_Cj-IIwhose corresponding R¹and R²are defined to be selected from the following structures: R^D1, R^D3, R^D4, R^D5, R^D9, R^D17, R^D22, R^D43, R^D50, R^D78, R^D116, R^D118, R^D133, R^D134, R^D135, R^D136, R^D143, R^D144, R^D145, R^D146, R^D149, R^D151, R^D154, R^D155, and R^D190.

[0089] In some of the above embodiments of the compound having the formula of M(L_A)_p(L_B)_q(L_C)_r, wherein L_Aand L_Bare as defined above, and L_Ccan be selected from the group consisting of:

[0090] In some embodiments, the compound can have formula Ir(L_A)₃, wherein the possible structures for L_Aare defined above.

[0091] In some embodiments, the compound can have formula Ir(L_A)(L_Bk)₂, wherein k is an integer from 1 to 324, and the compound is selected from the group consisting of Ir(L_A)(L_B1)₂to Ir(L_A)(L_B324)₂, wherein the structures of L_Aand L_Bkare as defined above.

[0092] In some embodiments, the compound can have formula Ir(L_A)₂(L_Cj-I), wherein j is an integer from 1 to 768, and the compound is selected from the group consisting of Ir(L_A)₂(L_Cj-I) to Ir(L_A)₂(L_C768-I), wherein the structures of L_Aand L_Cj-Iare as defined above.

[0093] In some embodiments, the compound can have formula Ir(L_A)₂(L_Cj-II), wherein j is as defined above, and the compound is selected from the group consisting of Ir(L_A)₂(L_Cj-II) to Ir(L_A)₂(L_C768-II), wherein the structures of L_Aand L_Cj-Iare as defined above.

[0094] In some embodiments, the compound can have formula Ir(L_A)(L_Bk)(L_Cj-I), wherein k and j are as defined above, and the compound is selected from the group consisting of Ir(L_A)(L_B1)(L_C1-I) to Ir(L_A)(L_B264)(L_C768-I), wherein the structures of L_A, L_Bk, and L_Cj-Iare all as defined above.

[0095] In some embodiments, the compound can have formula Ir(L_A)(L_Bk)(L_Cj-II), wherein k and j are as defined above, and the compound is selected from the group consisting of Ir(L_A)(L_B1)(L_C1-II) to Ir(L_A)(L_B264)(L_C768-II), wherein the structures of L_A, L_Bk, and L_Cj-IIare all as defined above.

[0096] In some embodiments, the compound has a formula Ir(L_Aa-b-c)₃, wherein a is an integer from 1 to 20, b is an integer from 1 to 14, and c is an integer from 1 to 151, and the compound is selected from the group consisting of Ir(L_A1-1-1)₃to Ir(L_A20-14-151)₃, wherein the structures of L_Aa-b-care as defined above. In some embodiments, the compound has a formula Ir(L_Aa-b-c)(L_Bk)₂, wherein a, b, and c are as defined above, and k is an integer from 1 to 324, and the compound is selected from the group consisting of Ir(L_A1-1-1)(L_B1)₂to Ir(L_A20-14-151)(L_B324)₂, wherein the structures of L_Aa-b-cand L_Bkare as defined above. In some embodiments, the compound has a formula Ir(L_Aa-b-c)₂(L_Cj), wherein a, b, and c are as defined above, and j is an integer from 1 to 768, and the compound is selected from the group consisting of Ir(L_A1-1-1)₂(L_C1) to Ir(L_A20-14-151)₂(L_C768), wherein the structures of L_Aa-b-cand L_Cjare as defined above.

[0097] In some of the above embodiments, the compound can be selected from the group consisting of:

[0098] In some embodiments, the compound having a ligand L_Aof Formula I described herein can be at least 30% deuterated, at least 40% deuterated, at least 50% deuterated, at least 60% deuterated, at least 70% deuterated, at least 80% deuterated, at least 90% deuterated, at least 95% deuterated, at least 99% deuterated, or 100% deuterated. As used herein, percent deuteration has its ordinary meaning and includes the percent of possible hydrogen atoms (e.g., positions that are hydrogen or deuterium) that are replaced by deuterium atoms.)

C. The OLEDs and the Devices of the Present Disclosure

[0099] In another aspect, the present disclosure also provides an OLED device comprising a first organic layer that contains a compound as disclosed in the above compounds section of the present disclosure.

[0100] In some embodiments, the OLED comprises an anode, a cathode, and a first organic layer disposed between the anode and the cathode. The first organic layer can comprise a compound comprising a ligand L_Aof Formula I

wherein rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X¹-X⁸are each independently C or N; no more than two X¹-X⁸in the same ring are N; X¹-X⁴is C if it is attached to Z¹; Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′; Z¹and Z²are each independently C or N; R^A, R^B, R^C, and R^Deach represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; R, R′, R^A, R^B, R^C, and R^Dare each independently a hydrogen or a substituent selected from the group consisting of the general substituents as defined above; at least one R^Dis a carbocyclic or heterocyclic group; and any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring, wherein the ligand L_Ais coordinated to a metal M forming a 5-membered chelate ring; wherein M can be coordinated to other ligands; and wherein the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

[0101] In some embodiments, the organic layer may be an emissive layer and the compound as described herein may be an emissive dopant or a non-emissive dopant.

[0102] In some embodiments, the organic layer may further comprise a host, wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan, wherein any substituent in the host is an unfused substituent independently selected from the group consisting of C_nH_2n+1, OC_nH_2n+1, OAr₁, N(C_nH_2n+1)₂, N(Ar₁)(Ar₂), CH═CH—C_nH_2n+1, C≡CC_nH_2n+1, Ar₁, Ar₁-Ar₂, C_nH_2n—Ar₁, or no substitution, wherein n is from 1 to 10; and wherein Ar₁and Ar₂are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.

[0103] In some embodiments, the organic layer may further comprise a host, wherein host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine, aza-triphenylene, aza-cathazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

[0104] In some embodiments, the host may be selected from the HOST Group consisting of:

and combinations thereof.

[0105] In some embodiments, the organic layer may further comprise a host, wherein the host comprises a metal complex.

[0106] In some embodiments, the compound as described herein may be a sensitizer; wherein the device may further comprise an acceptor; and wherein the acceptor may be selected from the group consisting of fluorescent emitter, delayed fluorescence emitter, and combination thereof.

[0107] In yet another aspect, the OLED of the present disclosure may also comprise an emissive region containing a compound as disclosed in the above compounds section of the present disclosure.

[0108] In some embodiments, the emissive region can comprise a compound comprising a ligand L_Aof Formula I

[0109] In some embodiments of the emissive region, the compound can be an emissive dopant or a non-emissive dopant. In some embodiments, the emissive region further comprises a host, wherein the host contains at least one group selected from the group consisting of metal complex, triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene). In some embodiments, the emissive region further comprises a host, wherein the host is selected from the Host Group defined above.

[0110] In some embodiments, at least one of the anode, the cathode, or a new layer disposed over the organic emissive layer functions as an enhancement layer. The enhancement layer comprises a plasmonic material exhibiting surface plasmon resonance that non-radiatively couples to the emitter material and transfers excited state energy from the emitter material to non-radiative mode of surface plasmon polariton. The enhancement layer is provided no more than a threshold distance away from the organic emissive layer, wherein the emitter material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant. In some embodiments, the OLED further comprises an outcoupling layer. In some embodiments, the outcoupling layer is disposed over the enhancement layer on the opposite side of the organic emissive layer. In some embodiments, the outcoupling layer is disposed on opposite side of the emissive layer from the enhancement layer but still outcouples energy from the surface plasmon mode of the enhancement layer. The outcoupling layer scatters the energy from the surface plasmon polaritons. In some embodiments this energy is scattered as photons to five space. In other embodiments, the energy is scattered from the surface plasmon mode into other modes of the device such as but not limited to the organic waveguide mode, the substrate mode, or another waveguiding mode. If energy is scattered to the non-free space mode of the OLED other outcoupling schemes could be incorporated to extract that energy to free space. In some embodiments, one or more intervening layer can be disposed between the enhancement layer and the outcoupling layer. The examples for interventing layer(s) can be dielectric materials, including organic, inorganic, perovskites, oxides, and may include stacks and/or mixtures of these materials.

[0111] The enhancement layer modifies the effective properties of the medium in which the emitter material resides resulting in any or all of the following: a decreased rate of emission, a modification of emission line-shape, a change in emission intensity with angle, a change in the stability of the emitter material, a change in the efficiency of the OLED, and reduced efficiency roll-off of the OLED device. Placement of the enhancement layer on the cathode side, anode side, or on both sides results in OLED devices which take advantage of any of the above-mentioned effects. In addition to the specific functional layers mentioned herein and illustrated in the various OLED examples shown in the figures, the OLEDs according to the present disclosure may include any of the other functional layers often found in OLEDs.

[0112] The enhancement layer can be comprised of plasmonic materials, optically active metamaterials, or hyperbolic metamaterials. As used herein, a plasmonic material is a material in which the real part of the dielectric constant crosses zero in the visible or ultraviolet region of the electromagnetic spectrum. In some embodiments, the plasmonic material includes at least one metal. In such embodiments the metal may include at least one of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca alloys or mixtures of these materials, and stacks of these materials. In general, a metamaterial is a medium composed of different materials where the medium as a whole acts differently than the sum of its material parts. In particular, we define optically active metamaterials as materials which have both negative permittivity and negative permeability. Hyperbolic metamaterials, on the other hand, are anisotropic media in which the permittivity or permeability are of different sign for different spatial directions. Optically active metamaterials and hyperbolic metamaterials are strictly distinguished from many other photonic structures such as Distributed Bragg Reflectors (“DBRs”) in that the medium should appear uniform in the direction of propagation on the length scale of the wavelength of light. Using terminology that one skilled in the art can understand: the dielectric constant of the metamaterials in the direction of propagation can be described with the effective medium approximation. Plasmonic materials and metamaterials provide methods for controlling the propagation of light that can enhance OLED performance in a number of ways.

[0113] In some embodiments, the enhancement layer is provided as a planar layer. In other embodiments, the enhancement layer has wavelength-sized features that are arranged periodically, quasi-periodically, or randomly, or sub-wavelength-sized features that are arranged periodically, quasi-periodically, or randomly. In some embodiments, the wavelength-sized features and the sub-wavelength-sized features have sharp edges.

[0114] In some embodiments, the outcoupling layer has wavelength-sized features that are arranged periodically, quasi-periodically, or randomly, or sub-wavelength-sized features that are arranged periodically, quasi-periodically, or randomly. In some embodiments, the outcoupling layer may be composed of a plurality of nanoparticles and in other embodiments the outcoupling layer is composed of a pluraility of nanoparticles disposed over a material. In these embodiments the outcoupling may be tunable by at least one of varying a size of the plurality of nanoparticles, varying a shape of the plurality of nanoparticles, changing a material of the plurality of nanoparticles, adjusting a thickness of the material, changing the refractive index of the material or an additional layer disposed on the plurality of nanoparticles, varying a thickness of the enhancement layer , and/or varying the material of the enhancement layer. The plurality of nanoparticles of the device may be formed from at least one of metal, dielectric material, semiconductor materials, an alloy of metal, a mixture of dielectric materials, a stack or layering of one or more materials, and/or a core of one type of material and that is coated with a shell of a different type of material. In some embodiments, the outcoupling layer is composed of at least metal nanoparticles wherein the metal is selected from the group consisting of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca, alloys or mixtures of these materials, and stacks of these materials. The plurality of nanoparticles may have additional layer disposed over them. In some embodiments, the polarization of the emission can be tuned using the outcoupling layer. Varying the dimensionality and periodicity of the outcoupling layer can select a type of polarization that is preferentially outcoupled to air. In some embodiments the outcoupling layer also acts as an electrode of the device.

[0115] In yet another aspect, the present disclosure also provides a consumer product comprising an organic light-emitting device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer may comprise a compound as disclosed in the above compounds section of the present disclosure.

[0116] In some embodiments, the consumer product comprises an OLED having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound comprising a ligand L_Aof Formula I

[0117] In some embodiments, the consumer product can be one of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, a light therapy device, and a sign.

[0118] Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

[0119] Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

[0120] The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

[0121] More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

[0122] FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

[0123] More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F₄-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

[0124] FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

[0125] The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the present disclosure may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.

[0126] Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

[0127] Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP, also referred to as organic vapor jet deposition (OVJD)), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink jet and organic vapor jet printing (OVJP). Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbmnched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons are a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

[0128] Devices fabricated in accordance with embodiments of the present disclosure may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

[0129] Devices fabricated in accordance with embodiments of the present disclosure can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the present disclosure can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. A consumer product comprising an OLED that includes the compound of the present disclosure in the organic layer in the OLED is disclosed. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, a light therapy device, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present disclosure, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25° C.), but could be used outside this temperature range, for example, from −40 degree C. to +80° C.

[0130] More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

[0131] The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

[0132] In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.

[0133] In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises a RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a lighting panel.

[0134] In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence; see, e.g., U.S. application Ser. No. 15/700,352, which is hereby incorporated by reference in its entirety), triplet-triplet annihilation, or combinations of these processes. In some embodiments, the emissive dopant can be a racemic mixture, or can be enriched in one enantiomer. In some embodiments, the compound can be homoleptic (each ligand is the same). In some embodiments, the compound can be heteroleptic (at least one ligand is different from others). When there are more than one ligand coordinated to a metal, the ligands can all be the same in some embodiments. In some other embodiments, at least one ligand is different from the other ligands In some embodiments, every ligand can be different from each other. This is also true in embodiments where a ligand being coordinated to a metal can be linked with other ligands being coordinated to that metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligands Thus, where the coordinating ligands are being linked together, all of the ligands can be the same in some embodiments, and at least one of the ligands being linked can be different from the other ligand(s) in some other embodiments.

[0135] In some embodiments, the compound can be used as a phosphorescent sensitizer in an OLED where one or multiple layers in the OLED contains an acceptor in the form of one or more fluorescent and/or delayed fluorescence emitters. In some embodiments, the compound can be used as one component of an exciplex to be used as a sensitizer. As a phosphorescent sensitizer, the compound must be capable of energy transfer to the acceptor and the acceptor will emit the energy or further transfer energy to a final emitter. The acceptor concentrations can range from 0.001% to 100%. The acceptor could be in either the same layer as the phosphorescent sensitizer or in one or more different layers. In some embodiments, the acceptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission can arise from any or all of the sensitizer, acceptor, and final emitter.

[0136] According to another aspect, a formulation comprising the compound described herein is also disclosed.

[0137] The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.

[0138] In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, electron blocking material, hole blocking material, and an electron transport material, disclosed herein.

[0139] The present disclosure encompasses any chemical structure comprising the novel compound of the present disclosure, or a monovalent or polyvalent variant thereof. In other words, the inventive compound, or a monovalent or polyvalent variant thereof, can be a part of a larger chemical structure. Such chemical structure can be selected from the group consisting of a monomer, a polymer, a macromolecule, and a supramolecule (also known as supermolecule). As used herein, a “monovalent variant of a compound” refers to a moiety that is identical to the compound except that one hydrogen has been removed and replaced with a bond to the rest of the chemical structure. As used herein, a “polyvalent variant of a compound” refers to a moiety that is identical to the compound except that more than one hydrogen has been removed and replaced with a bond or bonds to the rest of the chemical structure. In the instance of a supramolecule, the inventive compound can also be incorporated into the supramolecule complex without covalent bonds.

D. Combination of the Compounds of the Present Disclosure with Other Materials

[0140] The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

a) Conductivity Dopants:

[0141] A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.

[0142] Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047, and US2012146012.

b) HIL/HTL:

[0143] A hole injecting/transporting material to be used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphoric acid and silane derivatives; a metal oxide derivative, such as MoO_x; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

[0144] Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:

[0145] Each of Ar¹to Ar⁹is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

[0146] In one aspect, Ar¹to Ar⁹is independently selected from the group consisting of:

wherein k is an integer from 1 to 20; X¹⁰¹to X¹⁰⁸is C (including CH) or N; Z¹⁰¹is NAr¹, O, or S; Ar¹has the same group defined above.

[0147] Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

wherein Met is a metal, which can have an atomic weight greater than 40; (Y¹⁰¹-Y¹⁰²) is a bidentate ligand, Y¹⁰¹and Y¹⁰²are independently selected from C, N, O, P, and S; L¹⁰¹is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

[0148] In one aspect, (Y¹⁰¹-Y¹⁰²) is a 2-phenylpyridine derivative. In another aspect, (Y¹⁰¹-Y¹⁰²) is a carbene ligand In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc⁺/Fc couple less than about 0.6 V.

[0149] Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Pat. No. 6,517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.

c) EBL:

[0150] An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

d) Hosts:

[0151] The light emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.

[0152] Examples of metal complexes used as host are preferred to have the following general formula:

wherein Met is a metal; (Y¹⁰³-Y^104,)is a bidentate ligand, Y¹⁰³and Y¹⁰⁴are independently selected from C, N, O, P, and S; L¹⁰¹is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

[0153] In one aspect, the metal complexes are:

wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

[0154] In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y¹⁰³-Y¹⁰⁴) is a carbene ligand.

[0155] In one aspect, the host compound contains at least one of the following groups selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

[0156] In one aspect, the host compound contains at least one of the following groups in the molecule:

wherein R¹⁰¹is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20. X¹⁰¹to x¹⁰⁸are independently selected from C (including CH) or N. Z¹⁰¹and Z¹⁰²are independently selected from NR¹⁰¹, O, or S.

[0157] Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472, US20170263869, US20160163995, U.S. Pat. No. 9,466,803,

e) Additional Emitters:

[0158] One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

[0159] Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Pat. Nos. 6,699,599, 6,916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.

f) HBL:

[0160] A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.

[0161] In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

[0162] In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

wherein k is an integer from 1 to 20; L¹⁰¹is another ligand, k′ is an integer from 1 to 3.

g) ETL:

[0163] Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

[0164] In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

wherein R¹⁰¹is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar¹to Ar³has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X¹⁰¹to X¹⁰⁸is selected from C (including CH) or N.

[0165] In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:

wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L¹⁰¹is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

[0166] Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,

h) Charge Generation Layer (CGL)

[0167] In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

[0168] In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. The minimum amount of hydrogen of the compound being deuterated is selected from the group consisting of 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99%, and 100%. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.

[0169] It is understood that the various embodiments described herein are by way of example only and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.

E. Experimental Data

[0170] Synthesis of Inventive Example Compound (L_A1-5-9)(L_B28)₂

[0171] Step 1: Dibenzo[b,d]furan-4-ylboronic acid (24.85 g, 117.3 mmol), 4-bromo-1,1′-biphenyl (28.69 g, 123.1 mmol) and tetrakis(triphenylphosphine)palladium (0) (2.97 g, 2.57 mmol) were charged into the reaction mixture with 600 mL of toluene. Sodium carbonate (37.27 g, 351 mmol) was dissolved in 120 mL of water then was charged into the reaction mixture. This mixture was degassed with nitrogen then was heated to reflux overnight. The toluene layer was separated and concentrated under vacuum. The crude product was passed through a silica gel plug. The isolated product was recrystallized twice from DCM/methanol. 4-([1,1′-biphenyl]-4-yl) dibenzo[b,d]furan (24.7 g, 77 mmol, 65.7% yield) was isolated as a white solid.

[0172] Step 2: 4-([1,1′-biphenyl]-4-yDdibenzo[b,d]furan (8 g, 24.97 mmol) was dissolved in 200 mL of THF then was cooled to −78° C. Sec-Butyllithium in cyclohexane (33.9 ml, 47.4 mmol) was added to the cooled reaction mixture. The reaction mixture was then stirred at −70° to −60° C. for 2.5 hours. 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (10.22 g, 54.9 mmol) was then added to the reaction mixture. Stirring was continued as the reaction mixture was allowed to gradually warm to room temperature overnight. The reaction mixture was then quenched with aqueous ammonium chloride then was extracted 2× with 400 mL of ethyl acetate. The crude product was passed through a silica gel column The product was recrystallized from DCM/heptanes. 2-(6-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (6.4 g, 14.34 mmol, 57.4% yield) was isolated as a white solid.

[0173] Step 3: 2-(6-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.2 g, 7.17 mmol), 2-chloro-4-(2,2-dimethylpropyl-1,1-d2)-5-(methyl-d3)pyridine (1.599 g, 7.89 mmol), potassium carbonate (2.97 g, 21.51 mmol), tetrakis (triphenylphosphine)-palladium(0) (0.331 g, 0.287 mmol), dioxane (90 ml) and water (10 ml) were added to a 250 ml round bottom flask. The reaction mixture was heated to reflux for overnight. The reaction mixture was diluted with 100 ml water and extracted with 2×100 ml DCM. The extracts were washed with water, dried and evaporated to dryness. The residue was purified by column chromatography (SiO₂) to yield the desired product (2.3 g).

[0174] Step 4: Iridium precursor (1.845 g, 2.36 mmol), 2-(6-([1,1′-biphenyl]-4-yDdibenzo[b,d]furan-4-yl)-4-(2,2-dimethylpropyl-1,1-d2)-5-(methyl-d3)pyridine (2.3 g, 4.73 mmol), 2-ethoxyethanol (50 ml) and DMF (50.0 ml) were added to a 500 ml round bottom flask. The reaction was heated to 100° C. under nitrogen for a period of 7 days. The solvent was removed by evaporation and the residue was subjected to column chromatography (SiO₂) to yield the desired product.

[0175] Synthesis of Comparative Example

Scheme

[0176]

[0177] Step. 1: A 3 L round bottom flask, equipped with a stir bar, was charged with di-μ-chloro-tetrakis[κ2(C2,N)-bis(5-(methyl-d₃)-2-(4-methyl-d₃)-phenyl-2′-yl)-pyridin-1-yl]diiridium(III) (50 g, 41.4 mmol, 1.0 equiv) and dichloromethane (1077 mL). The flask was wrapped with aluminum foil to exclude light and a solution of silver trifluoromethanesulfonate (23.4 g, 91 mmol, 2.2 equiv) in methanol (215 mL) was added. The reaction mixture was stirred overnight at room temperature under nitrogen. The mixture was filtered through a short silica gel pad (300 g), which was washed with dichloromethane (3×500 mL). The filtrate was concentrated under reduced pressure and the residue dried under vacuum overnight at ˜40° C. to give [Ir(5-(methyl-d₃)-2-(4-d₃-methylphenyl-2′-yl)-pyridin-1-yl(-1H))₂(MeOH)₂] trifluoromethanesulfonate (68.8 g) as a dark yellow solid.

[0178] Step 2: To a 250 mL 4-neck round bottom flask equipped with a thermocouple, a condenser and a stir bar were added 2-(dibenzofuran-4-yl)-4-(2,2-dimethylpropyl-1,1-d₂)-5-(methyl-d₃)pyridine (1.2 g, 3.5 mmol, 1.05 equiv), [Ir(5-(methyl-d₃)-2-(4-d₃-methylphenyl-2′yl)-pyridin-1-yl(-1H))₂-(MeOH)₂] trifluoromethanesulfonate (2.6 g, 3.3 mmol, 1.0 equiv), and ethanol (75 mL). The reaction mixture was heated at 70° C. for 10 hours at which time LCMS analysis indicated ˜30% conversion to the desired product. 2,6-Lutidine (0.07 g, 0.6 mmol, 0.2 equiv) was added and heating continued at 70° C. for 5 hours. After cooling to room temperature, the reaction was filtered and the solid was washed with methanol (3×15 mL). The solid was purified on an Interchim PuriFlash XS 420 automated system (3×80 g silica gel cartridges, stacked) topped with basic alumina (25 g), eluting with a gradient of 20 to 32% dichloromethane in heptanes. The recovered yellow solid was dissolved in minimal dichloromethane (˜5 mL), methanol (500 mL) was added and the suspension stirred for 20 minutes. The suspension was filtered, and the filtrate concentrated to a heal. Methanol (200 mL) was added and suspension filtered. The combined solids were dried to give bis[5-(methyl-d₃)-2-(4-(methyl-d₃)-phenyl-2′-yl)pyridin-1-yl]-[2-((dibenzo[b,d]furan-4-yl)-3′-yl)-4-(2,2-dimethylpropyl-1,1-d₂)-5-(methyl-d₃)pyridin-1-yl] iridium(III) (0.6 g, 19% yield, 99.4% UHPLC purity) as a yellow solid.

[0179] Device Examples

[0180] All example devices were fabricated by high vacuum (<10⁻⁷Torr) thermal evaporation. The anode electrode was 800 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of Liq (8-hydroxyquinoline lithium) followed by 1,000 Å of Al. All devices were encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H₂O and O₂) immediately after fabrication with a moisture getter incorporated inside the package. The organic stack of the device examples consisted of sequentially, from the ITO Surface: 100 Å of HAT-CN as the hole injection layer (HIL); 450 Å of HTM as a hole transporting layer (HTL); emissive layer (EML) with thickness 400 Å. Emissive layer containing H-host (H1): E-host (H2) in 6:4 ratio and 12 weight % of green emitter. 350 Å of Liq (8-hydroxyquinoline lithium) doped with 40% of ETM as the ETL. Device structure is shown in Table 4 below. Table 4 shows the schematic device structure. The chemical structures of the device materials are shown below.

[0181] Upon fabrication, the devices were measured for electro luminesence (EL), JVL characteristics and lifetested at DC 80 mA/cm². LT95 at 1,000 nits was calculated from 80 mA/cm2 LT data assuming acceleration factor 1.8. Device performance is shown in the Table 5.

TABLE 4

schematic device structure
	Layer	Material	Thickness [Å]

	Anode	ITO	800
	HIL	HAT-CN	100
	HTL	HTM	400
	EBL	EBM	50
	Green	H1:H2: example dopant	400
	EML
	ETL	Liq:ETM 40%	350
	EIL	Liq	10
	Cathode	Al	1,000

TABLE 5

Device performance
	1931 CIE	At 10 mA/cm²*
			λ max	FWHM	Voltage	LE	EQE	PE
Emitter 12%	x	y	[nm]	[nm]	[V]	[cd/A]	[%]	[lm/W]

Inventive	0.319	0.636	520	60	1.05	1.02	1.02	1.01
Example
Comparative	0.321	0.633	520	63	1.00	1.00	1.00	1.00
Example

*The data is normalized to comparative example

[0182] Comparing inventive example with the comparative example; the inventive example exhibited a narrower FWHM, which is normally very difficult to achieve. The inventive example also exhibited higher efficiency parameters than the comparative example. Presumably the biphenyl substitution in the dibenzofuran has better alignment with transition dipolar moment of the molecular. The transition dipolar moment of the inventive compound (L_A1-5-9)(L_B28)₂is shown in FIG. 3.

[0183] In summary, the inventive compounds described here have significant improvement over the comparative one, which is already one of the commercial grade families with top performance in each parameter.

Claims

What is claimed is:

1. A compound comprising a ligand LA of Formula I

wherein:

rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

X¹-X⁸are each independently C or N;

no more than two X¹-X⁸in the same ring are N;

X¹-X⁴is C if it is attached to Z¹;

Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′;

Z¹and Z²are each independently C or N;

R^A, R^B, and R^Ceach represent zero, mono, up to the maximum number of allowed substitutions to its associated ring;

R^Drepresents mono, up to a maximum allowed substitution to its associated ring;

R, R′, R^A, R^B, R^C, and R^Dare each independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

at least one R^Dis a carbocyclic or heterocyclic group, and

any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring,

the ligand L_Ais coordinated to a metal M through the two dashed lines forming a 5-membered chelate ring;

M can be coordinated to other ligands; and

the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

2. The compound of claim 1, wherein R, R′, R^A, R^B, R^C, and R^Dare each independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

3. The compound of claim 1, wherein Y is selected from the group consisting of O and S.

4. The compound of claim 1, wherein ring A is selected from the group consisting of pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, triazole, pyrazole, and N-heterocyclic carbene.

5. The compound of claim 1, wherein each X¹-X⁸is C.

6. The compound of claim 1, wherein at least one of X¹-X⁸is N.

7. The compound of claim 1, wherein one of X¹-X⁴is N and is coordinated to M.

8. The compound of claim 1, wherein ring D is a 6-membered aromatic ring.

9. The compound of claim 1, wherein at least one R^Dis a substituted or unsubstituted 6-membered aromatic ring; or 5-membered or 6-membered aliphatic ring, which can be further substituted.

10. The compound of claim 1, wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au.

11. The compound of claim 1, wherein the ligand L_Ais selected from the group consisting of:

wherein X⁹to X¹³can each be independently C or N and Y¹is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′.

12. The compound of claim 1, wherein the ligand L_Ais L_Aa-b-chaving the structure of Formula II


	Pyridine	Aryl	Ligation
a	POA	POA	position	R^B	R^C


1.	4	6	3	H	H
2.	3	6	2	H	H
3.	2	6	3	H	H
4.	4	7	3	H	H
5.	3	7	2	H	H
6.	2	7	3	H	H
7.	4	8	3	H	H
8.	3	8	2	H	H
9.	2	8	3	H	H
10.	2	6	3	H	H
11.	2	7	3	H	H
12.	2	8	3	H	H
13.	2	9	3	H	H
14.	4	9	3	H	H
15.	3	9	2	H	H
16.	2	9	3	H	H
17.	4	6	3	H	7,9-CD₃
18.	4	6	3	1-CD₃	H
19.	4	3	6	1-CD₃	8-CD₃
20.	4	3	6	H	7-CD₃

wherein the Pyridine substituent in Formula II has the structure of Formula III

and for each b, the substituents R^A1and R^A2are defined as provided below:


b	R^A1	R^A2


1.	H	CD₃
2.	CD₃	H
3.	CD₃	CD₃
4.	CD₃	CDMe₂
5.	CD₃	CD₂CMe₃
6.	CD₃	CMe₃
7.	H	CDMe₂
8.	H	CD₂CMe₃
9.	H	CMe₃
10.	CD₂CMe₃	CD₂CMe₃
11.	CD₃	Ph

12.	H

13.	H

14.	H

wherein for each c, the Aryl substituent in Formula II has the structure of Formula E*-D*-, wherein for each c, D* and E* are defined as provided below, wherein D* can consist of 1 to 3 groups from D₁to D₁₂attached in conjunction:


c	D*	E*


1.	D_1-#	E₃
2.	D_1-#	E₄
3.	D_1-#	E₅
4.	D_1-#	E₆
5.	D_6-#	E₃
6.	D_6-#	E₄
7.	D_6-#	E₅
8.	D_6-#	E₆
9.	D₁D_1-#	H
10.	D₁D_1-#	E₁
11.	D₁D_1-#	E₂
12.	D₁D_1-#	E₃
13.	D₁D_1-#	E₄
14.	D₁D_1-#	E₅
15.	D₁D_1-#	E₆
16.	D₁D_1-#	E₇
17.	D₁D_1-#	E₈
18.	D₁D_2-#	H
19.	D₁D_2-#	E₂
20.	D₁D_2-#	E₃
21.	D₂D_1-#	E₁
22.	D₁D_1-#	H
23.	D₁D_1-#	E₁
24.	D₁D_1-#	E₂
25.	D₁D_1-#	E₃
26.	D₁D_1-#	E₄
27.	D₁D_1-#	E₅
28.	D₁D_1-#	E₆
29.	D₁D_1-#	E₇
30.	D₁D_1-#	E₈
31.	D₁D_1-#	E₉
32.	D₁D_1-#	CD₃
33.	D₁D_2-#	E₇
34.	D₁D_2-#	E₈
35.	D₂D_2-#	E₅
36.	D₁D_2-#	CD₃
37.	D₂D_1-#	E₂
38.	D₂D_1-#	E₃
39.	D₁D_3-#	E₁
40.	D₁D_3-#	E₂
41.	D₁D_3-#	E₃
42.	D₁D_3-#	E₄
43.	D₁D_3-#	E₅
44.	D₁D_3-#	E₆
45.	D₁D_3-#	E₇
46.	D₁D_3-#	E₈
47.	D₁D_3-#	E₉
48.	D₁D_3-#	CD₃
49.	D₁D_3-#	H
50.	D₃D_1-#	E₁
51.	D₃D_1-#	E₂
52.	D₃D_1-#	E₃
53.	D₃D_1-#	E₄
54.	D₃D_1-#	E₅
55.	D₃D_1-#	E₆
56.	D₃D_1-#	E₇
57.	D₃D_1-#	E₈
58.	D₄D_1-#	E₂
59.	D₄D_1-#	E₃
60.	D₄D_1-#	E₄
61.	D₄D_1-#	E₅
62.	D₄D_1-#	E₆
63.	D₄D_1-#	E₇
64.	D₄D_1-#	E₈
65.	D₁D_4-#	E₁
66.	D₁D_4-#	E₂
67.	D₁D_4-#	E₃
68.	D₁D_4-#	E₄
69.	D₁D_4-#	E₅
70.	D₁D_4-#	E₆
71.	D₁D_4-#	E₇
72.	D₁D_4-#	E₈
73.	D₂D_5-#	E₁
74.	D₂D_5-#	E₂
75.	D₂D_5-#	E₃
76.	D₂D_5-#	E₄
77.	D₂D_5-#	E₅
78.	D₂D_5-#	E₆
79.	D₂D_5-#	E₇
80.	D₂D_5-#	E₈
81.	D₂D_5-#	E₉
82.	D₅D_2-#	E₁
83.	D₅D_2-#	E₂
84.	D₅D_2-#	E₃
85.	D₅D_2-#	E₄
86.	D₅D_2-#	E₅
87.	D₅D_2-#	E₆
88.	D₅D_2-#	E₇
89.	D₅D_2-#	E₈
90.	D₅D_2-#	E₉
91.	D₆D_6-#	H
92.	D₆D_6-#	CD₃
93.	D₆D_6-#	E₁
94.	D₆D_6-#	E₂
95.	D₆D_6-#	E₃
96.	D₆D_6-#	E₄
97.	D₆D_6-#	E₅
98.	D₆D_6-#	E₆
99.	D₆D_6-#	E₇
100.	D₆D_6-#	E₈
101.	D₆D_6-#	E₉
102.	D₈D_8-#	E₁
103.	D₈D_8-#	E₂
104.	D₈D_8-#	E₃
105.	D₈D_8-#	E₄
106.	D₈D_8-#	E₅
107.	D₈D_8-#	E₆
108.	D₈D_8-#	E₇
109.	D₈D_8-#	E₈
110.	D₈D_8-#	E₉
111.	D₉D_1-#	E₂
112.	D₉D_1-#	E₄
113.	D₉D_1-#	E₅
114.	D₉D_1-#	E₆
115.	D₁₀D_1-#	E₂
116.	D₁₀D_1-#	E₄
117.	D₁₀D_1-#	E₅
118.	D₁₀D_1-#	CD₃
119.	D₁₁D_1-#	E₂
120.	D₁₁D_1-#	E₄
121.	D₁₁D_1-#	E₅
122.	D₁₁D_1-#	E₆
123.	D₁₂D_1-#	E₂
124.	D₁₂D_1-#	E₄
125.	D₁₂D_1-#	E₅
126.	D₁₂D_1-#	E₆
127.	D₁D₁D_1-#	H
128.	D₁D₁D_1-#	E₄
129.	D₁D₁D_1-#	E₅
130.	D₁D₁D_1-#	E₆
131.	D₂D₂D_1-#	E₂
132.	D₂D₂D_1-#	E₄
133.	D₂D₂D_1-#	E₅
134.	D₂D₂D_1-#	E₆
135.	D₂D₅D_1-#	E₂
136.	D₂D₅D_1-#	E₄
137.	D₂D₅D_1-#	E₅
138.	D₂D₅D_1-#	E₆
139.	D₅D₂D_1-#	E₂
140.	D₅D₂D_1-#	E₄
141.	D₅D₂D_1-#	E₅
142.	D₅D₂D_1-#	E₆
143.	D₅D₅D_1-#	E₂
144.	D₅D₅D_1-#	E₄
145.	D₅D₅D_1-#	E₅
146.	D₅D₅D_1-#	E₆
147.	D₆D₆D_6-#	E₂
148.	D₆D₆D_6-#	E₄
149.	D₆D₆D_6-#	E₅
150.	D₆D₆D_6-#	E₆
151.	D₁D₈D_8-#	H

wherein the groups D₁to D₁₂have the following structures:

wherein # shows attachment direction to dibezofuran/dibenzothiphene core, and * shows attachment direction to substituent E*; and wherein E1 to E9 are defined as follows:

13. The compound of claim 1, wherein ligand L_Ais selected from the group consisting of:

14. The compound of claim 1, wherein the compound has a formula of M(L_A)_p(L_B)_q(L_C)_rwherein L_Band L_Care each a bidentate ligand; and wherein p is 1, 2, or 3; q is 0, 1, or 2; r is 0, 1, or 2; and p+q+r is the oxidation state of the metal M; wherein L_Band L_Care each independently selected from the group consisting of:

wherein:

each Y¹to Y¹³are independently selected from the group consisting of carbon and nitrogen; Y′ is selected from the group consisting of BR_e, NR_e, PR_e, O, S, Se, C═O, S═O, SO₂, CR_eR_f, SiR_eR_f, and GeR_eR_f;

R_eand R_fcan be fused or joined to form a ring;

each R_a, R_b, R_c, and R_dindependently represents from zero, mono, or up to the maximum number of allowed substitutions to its associated ring;

each R_a, R_b, R_c, R_d, R_eand R_fis independently a hydrogen or a subsituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

any two adjacent substituents of R_a, R_b, R_c, and R_dcan be fused or joined to form a ring or form a multidentate ligand.

15. The compound of claim 12, wherein the compound has a formula Ir(L_Aa-b-c)(L_Bk)₂, wherein k is an integer from 1 to 324, and the compound is selected from the group consisting of Ir(L_A1-1-1)(L_B1)₂to Ir(L_A20-14-151)(L_B324)₂, wherein the structures of L_Bkare defined below:

16. The compound of the claim 14, wherein the compound is selected from the group consisting of:

17. An organic light emitting device (OLED) comprising:

an anode;

a cathode; and

an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound comprising a ligand L_Aof Formula I

wherein:

rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

X¹-X⁸are each independently C or N;

no more than two X¹-X⁸in the same ring are N;

X¹-X⁴is C if it is attached to Z¹;

Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′;

Z¹and Z²are each independently C or N;

R^A, R^B, R^C, and R^Deach represent zero, mono, up to the maximum number of allowed substitutions to its associated ring;

at least one R^Dis a carbocyclic or heterocyclic group, and

any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring,

the ligand L_Ais coordinated to a metal M through the two dashed lines forming a 5-membered chelate ring;

M can be coordinated to other ligands; and

the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

18. The OLED of claim 17, wherein the organic layer further comprises a host, wherein the host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, indolocarbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, 5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, 5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene, triazine, aza-triphenylene, aza-carbazole, aza-indolocarbazole, aza-dibenzothiophene, aza-dibenzofuran, aza-dibenzoselenophene, aza-5λ2-benzo[d]benzo[4,5]imidazo[3,2-a]imidazole, and aza-(5,9-dioxa-13b-boranaphtho[3,2,1-de]anthracene).

19. The OLED of claim 18, wherein the host is selected from the group consisting of:

and combinations thereof.

20. A consumer product comprising an organic light-emitting device (OLED) comprising:

an anode;

a cathode; and

an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound comprising a ligand L_Aof Formula I

wherein:

rings A and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

X¹-X⁸are each independently C or N;

no more than two X¹-X⁸in the same ring are N;

X¹-X⁴is C if it is attached to Z¹;

Y is selected from the group consisting of O, S, Se, NR, BR, CRR′, SiRR′, and GeRR′;

Z¹and Z²are each independently C or N;

R^A, R^B, R^C, and R^Deach represents zero, mono, up to the maximum number of allowed substitutions to its associated ring;

at least one R^Dis a carbocyclic or heterocyclic group, and

any two substituents can be joined or fused together to form a ring, with the proviso that R^Cand R^Ddo not join to form a ring,

the ligand L_Ais coordinated to a metal M through the two dashed lines forming a 5-membered chelate ring;

M can be coordinated to other ligands; and

the ligand L_Acan be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Description